SCHEMBL716833

SCHEMBL716833

CCC(N)CN1CCNCC1C

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.36
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9801831 0.82 DPP4 (0.35) DPP4TDP1
SCHEMBL3110552 0.81 TDP1 (0.35) TDP1
SCHEMBL6119073 0.80 TDP1 (0.33) TDP1
SCHEMBL10385640 0.79 DPP4 (0.34) DPP4TDP1
SCHEMBL12259540 0.78 PIK3CD (0.32) DPP4TDP1
SCHEMBL3101622 0.78 PIK3CD (0.32) DPP4TDP1
SCHEMBL12259539 0.78 PIK3CD (0.32) DPP4TDP1
SCHEMBL17906587 0.77 DPP4 (0.36) DPP4
SCHEMBL17906591 0.77 DPP4 (0.36) DPP4
Hydrochloric Acid SCHEMBL28719815 0.77 SMN1; SMN2 (0.31) DPP4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 353 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8703873-B2 Multiple function graft polymer CASTROL LIMITED (GB) 2014-04-22 US claimed
EP-2688989-A1 FUNCTIONALIZED MONOMERS Elevance Renewable Sciences, Inc. (US) 2014-01-29 EP claimed
EP-2688988-A2 FUNCTIONALIZED MONOMERS Elevance Renewable Sciences, Inc. (US) 2014-01-29 EP claimed
EP-2688990-A2 MALIENATED DERIVATIVES Elevance Renewable Sciences, Inc. (US) 2014-01-29 EP claimed
EP-2688925-A2 FUNCTIONALIZED POLYMERS Elevance Renewable Sciences, Inc. (US) 2014-01-29 EP claimed
WO-2013130372-A1 TERPENE DERIVED COMPOUNDS ELEVANCE RENEWABLE SCIENCES, INC. (US) 2013-09-06 WO claimed
US-20130225462-A1 TERPENE DERIVED COMPOUNDS ELEVANCE RENEWABLE SCIENCES, INC. (US) 2013-08-29 US claimed
EP-2552977-A1 MULTIPLE FUNCTION GRAFT POLYMER Castrol Limited (GB) 2013-02-06 EP claimed
US-20120283156-A1 FUNCTIONALIZED MONOMERS ELEVANCE RENEWABLE SCIENCES 2012-11-08 US claimed
US-20120277133-A1 FUNCTIONALIZED POLYMERS ELEVANCE RENEWABLE SCIENCES, INC. 2012-11-01 US claimed
EP-2501726-A1 MULTIFUNCTIONAL MULTIPLE GRAFT MONOMER LOW MOLECULAR WEIGHT POLYMER Castrol Limited (GB) 2012-09-26 EP claimed
US-20110287992-A1 MULTIFUNCTIONAL MULTIPLE GRAFT MONOMER LOW MOLECULAR WEIGHT POLYMER CASTROL LIMITED (US) 2011-11-24 US claimed
WO-2011123408-A1 MULTIPLE FUNCTION GRAFT POLYMER CASTROL LIMITED (GB) 2011-10-06 WO claimed
US-20110245119-A1 Multiple Function Graft Polymer CASTROL LIMITED (GB) 2011-10-06 US claimed
WO-2011062914-A1 MULTIFUNCTIONAL MULTIPLE GRAFT MONOMER LOW MOLECULAR WEIGHT POLYMER CASTROL LIMITED (GB) 2011-05-26 WO claimed
EP-1533293-B1 Preparation of functional monomers for grafting to low molecular weight polyalkenes and their use in the preparation of dispersants and lubricating oil compositions containing dispersant polyalkenes CASTROL LTD (GB) 2009-08-19 EP claimed
US-20080293600-A1 Multiple-Function Dispersant Graft Polymer CASTROL LIMITED (GB) 2008-11-27 US claimed
EP-1874837-A1 MULTIPLE-FUNCTION DISPERSANT GRAFT POLYMER CASTROL LIMITED (GB) 2008-01-09 EP claimed
WO-2006116663-A1 MULTIPLE-FUNCTION DISPERSANT GRAFT POLYMER CASTROL LIMITED (GB) 2006-11-02 WO claimed
US-6179885-B1 MIXTURE WITH ALCOHOL THE LUBRIZOL CORPORATION 2001-01-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277133-A1 FUNCTIONALIZED POLYMERS PARG, PUF60, ADH1C DPP4 4854/4885TDP1 1174/4885
US-20120283156-A1 FUNCTIONALIZED MONOMERS MEP1A, MLEC, ELANE DPP4 4683/4885TDP1 3103/4885
US-20130225462-A1 TERPENE DERIVED COMPOUNDS FDFT1, SQLE, FDPS DPP4 3670/4885TDP1 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.